A new mechanism for the treatment of cervical cancer reduces the relationships of death

In a study published in the journal “Lancet”, it is said that the addition of chemotherapy before radiotherapy significantly improves survival rates in people with non -preval cervical cancer. Although there is an increase in the percentage of serious side effects, the general benefit in improving survival rates makes this treatment a possible option in the future. Inception of chemotherapy is a type of chemotherapy given to the patient before the main treatment begins, which can be surgery or radiotherapy; It aims to reduce the size of the crop and it responds more to the most important treatment, whether it is a radiological or surgical treatment. It is also used to reduce the spread of cancer cells before radical therapy; This treatment is given over a specific period, and it often contains strong chemicals that target cancer cells, increasing the chances of controlling the crop and improving the results of the major treatment. The researchers conducted the study over 500 patients from 32 medical centers in Brazil, India, Italy, Mexico and the United Kingdom, which were randomly distributed in two groups between 2012 and 2022. Most patients had the cervical cervical cell cancer, with an average age of 46 years and 77% of participants in the second phase of the disease, and more than half of them (58%) were just of spreading the saving of saving the limit to saving the SPL nodes and patients for a medium period of 64 months. The first group received only radioactive chemotherapy, while the second group received “Carbplatine” treatment and chemotherapy “bacltaxel” before the start of radiation chemotherapy. And 92% of the patients of the second group in the chemotherapy group received at least 5 courses of carbplatin and bikaxel, and the average interval between chemotherapy and radiological chemotherapy was 7 days, and more than 80% of patients in both groups received at least 4 sepatin courses as part of radiological chemotherapy. ‘Cancer will not return’ and the researchers found that 80% of those who received a short course of chemotherapy lived at least five years, and 72% of them did not suffer from cancer return or distribution, and in the first group 72% of them lived at least five years, and 64% of them did not suffer from cancer. Despite the positive results that an improvement showed in survival rates, the researchers said that 58% of respondents were negative for the distribution of cancer to the lymph nodes; This limits the generalization of results in categories that are more at risk of relapse. The results also indicate that the addition of chemotherapy before radiotherapy significantly improves survival rates in patients with advanced cervical cancer without spreading to other organs. Inceptionial chemotherapy Most patients had some kind of side effect during treatment, including fatigue or weakness, digestive problems, infections or low white blood cells. Treatment also caused serious or life -threatening events at 59% of the group that received inflammatory chemotherapy, compared to 48% of those who received only radi chemotherapy. The researchers say that the study is the first random study of the third phase that shows a ‘major survival function’ using chemotherapy before radiotherapy, which is “a clinical improvement with a significant cost at a relatively low cost”.